Pharmaceutical Conference 2023 | Dubai | Pharma | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Enlightening the recent advances in Pharmaceutical Sciences & Drug Delivery

- Pharmaceutical Sciences 2023

About Conference

The 8th International Conference on Pharmaceutics & Advanced Drug Delivery Systems is scheduled to take place on December 04-06, 2023 at the Ghaya Grand Hotel-Dubai, UAE. The Pharmaceutical Conference 2023 is organized around the theme: Enlightening the recent advances in Pharmaceutical Sciences & Drug Delivery.

A three-day Pharmaceutical Conference with several key scientific sessions that offer thorough content covering various pharmaceutical industry sectors for professionals in the pharmaceutical and healthcare industries. The event offers the opportunity to learn and share ideas that will benefit the pharmacy and healthcare industry in the future.

WHO MAY ATTEND THE CONFERENCE?

Students
Professors
Pharmacy scientists
Pharmacologists
Toxicologists
Pharmacists
Business executives
Pharmaceutical Firms
Pharmaceutical Associations & Societies
Research Institutes
Research Scholars
Business professionals
Entrepreneurs
Specialists in medicine
Drug development firms
Biotechnologists
Nanotechnologist and Biomaterials Scientist
Biochemists
Drug Designers

Goal of the Conference

The pharmaceutical industry plays a major part in providing patients with the medications they need to recover. It aids in the discovery and development of novel medications that save many lives. The pharmaceutical business will be greatly impacted by a number of disruptive technologies and emerging trends.

Global Excellence in Pharmaceutical Sciences 2023

Outstanding Speakers and Parallel Events
Global Networking
Industry and Academic Attendance
Presentation of interdisciplinary research
Amazing Hospitality Experience
Industry Exhibitions
Awards and Certificate of Participation
Discover New Cultures
Learn New Emerging Technologies
Abstracts are published in conference proceedings.
Deep Learning and Knowledge Exchange Exposure to Future Trends
Evaluating and disseminating findings from the research
Find, Present, and Delight

Mark your calendar and attend the 8th International Conference on Pharmaceutics & Advanced Drug Delivery Systems this December!

Get in touch for Program Enquiries

Luna Grace
Program Manager | Pharmaceutical Sciences 2023
Follow us on LinkedIn | Twitter
WhatsApp: +44 1324 23800

Sessions & Tracks

Become a Presenter

1. Submit an abstract with the following details: presentation style, short/long descriptions, keywords, focus, subjects, and biographical information.

2 Get Approved: Within 24 hours of submittal, all abstracts will be evaluated by the Scientific Committee Panel.

3 Sign UP, once your proposal has been approved.

Track 01: Pharmaceutics & Pharmacology

Four main themes are the focus of the Division of Pharmaceutics and Pharmacology: (1) cancer therapeutics, (2) cell protective therapies, (3) drug delivery methods, and (4) drug toxicity.

(1) Cancer Therapeutics: the detection of drug resistance mechanisms, the discovery of anti-cancer drug targets, and the optimization of drug delivery to enhance outcomes for cancer patients.

(2) Cell Protective Therapies: The creation of therapies to lessen inflammatory and degenerative processes will be aided by preclinical research on the mechanisms of cell death and cell survival.

(3) Drug Delivery Systems: Future medications to treat human diseases will be developed using pharmaceutical chemistry, biotechnology, and RNA nanotechnology.

(4) Drug Toxicity: Understanding how drugs enter healthy cells and have toxic effects will assist with the development of patient-health improvement strategies.

Associated Journals: Advanced Drug Delivery Reviews | Journal of Pharmaceutical Analysis | Asian Journal of Pharmaceutical Sciences | International Journal of Pharmaceutics | Molecular Pharmaceutics

Track 02: Pharmacokinetics & Pharmacodynamics

Pharmacokinetics studies the body's absorption, distribution, metabolization, and excretion of a substance.

A drug's organ-specific mechanism of action and its biochemical and physiological effects, including effects at the cellular level, are studied by the discipline of pharmacodynamics.

Pharmacokinetics is “what the body does to the drug," whereas pharmacodynamics is “what the drug does to the body.”

Associated Journals: Journal of Pharmaceutical Analysis | Asian Journal of Pharmaceutical Sciences | International Journal of Pharmaceutics | Molecular Pharmaceutics | Advanced Drug Delivery Reviews

Track 03: Pharmacogenomics

By giving instructions on dosage, potential side effects, or differences in efficacy for individuals with particular gene variants, pharmacogenomic information on the labels of medications can help doctors tailor drug prescriptions for individual patients. Pharmacogenomics is also being used by pharmaceutical firms to create and sell medications for patients with particular genetic profiles.

Pharmacogenomics’ advantages

maximise a drug's or treatment's planned use.
minimise negative drug responses.
hasten the process of a drug's therapeutic advantage being realised.
reduce the likelihood of adverse impacts or dependency

Track 04: Pharmacognosy

Pharmacognosy is the study of natural medicines derived from living things like plants, microorganisms, and animals. Many significant medications still in use today, such as morphine, atropine, galantamine, etc., have their roots in nature and are still useful model molecules for drug development. Pharmacognosy also includes traditional medicine, and the majority of third-world nations still rely heavily on the use of plant remedies. Pharmacognosy is always in demand in the pharmaceutical sciences and is crucial to the development of new drugs.

Track 05: Pharmacogenomics

Pharmaceutical Formulation is a multi-step process that results in a helpful medicinal product by combining the active ingredient with all other ingredients while taking into account solubility, pH, polymorphism, and particle size. The four fundamental elements for a successful pharmaceutical formulation are the advantages and limitations of the active pharmaceutical ingredients (APIs), useful excipients, associated interactions, and manufacturing process. The formulation frequently works in a manner that incorporates various dosage forms. There are presently tens of thousands of medication formulations on the market that patients can use and clinicians can prescribe.

Track 06: Pharmaceutical Process Engineering

The full manufacturing process of drugs and medications is the emphasis of process engineering in the pharmaceutical sector.

Important obligations include:

establishing, assessing, and improving complete industrial processes, from conception to approval
choosing and incorporating new hardware and services
conducting routine risk analyses of equipment and procedures
reporting to senior management and assessing the process capacity of the equipment.

Track 07: Pharmaceutical Microbiology & Biotechnology

Pharmaceutical microbiology is the study of the particular microorganisms involved in the design, scalability, and production of pharmaceuticals as well as the following reduction or eradication of their numbers in a process environment. The study and development of anti-infectives, the use of microorganisms to screen potential medications for mutagenic and carcinogenic activity, and the use of microorganisms in the production of pharmaceuticals like insulin and human growth hormone are all additional facets of pharmaceutical microbiology.

Pharmaceutical Microbiology Involves

Endotoxin detection and testing
environmental testing and surveillance
Systems for Detecting Microbes
Testing and Detection of Mycoplasma

Pharmaceutical Biotechnology

Pharmaceutical biotechnology is a fresh and expanding field in which the biotechnological principles are used to create pharmaceuticals. Vaccines, nucleic acid products, and antibodies are examples of bioformulations that make up the bulk of therapeutic drugs on the market today. Understanding the fundamental molecular mechanisms governing the function of related biomolecules, their synthesis and purification, evaluation of the product's shelf life, stability, toxicity, and immunogenicity, development of drug delivery systems, patenting, and clinical trials are all steps in the development of such bioformulations.

Track 08: Pharmaceutical Nanotechnology

In the realm of pharmaceuticals and medicine, nanotechnology is regarded as a recent and quickly developing area. As drug delivery methods, nanoparticles offer a number of benefits in terms of increased efficacy and fewer negative drug reactions. The primary variables influencing nanoparticles' physical stability and biological performance of the incorporated drug are particle size, surface charge, surface hydrophobicity, and drug release. Numerous nanodrugs have been used in clinical practise for a variety of reasons and for both therapeutic and diagnostic purposes. Nanoparticles are used to treat renal conditions, tuberculosis, skin problems, Alzheimer's disease, various cancers, and to make COVID-19 vaccines.

Track 09: Pharmacovigilance: Significance & Scope

Pharmacovigilance is the study and practise concerned with the identification, evaluation, comprehension, and avoidance of side effects or any other issue involving drugs or vaccines. Before being approved for use, all medications and vaccines go through extensive clinical trials to test their safety and effectiveness. The health care team must be properly trained by national pharmacovigilance centres to identify and record any adverse drug events. The WHO has authorised these facilities, including those in nations participating in the WHO Program for International Drug Monitoring. The significance and roles of pharmacovigilance are important; they have grown over time to include a variety of patient safety-related fields.

Track 10: Sports Pharmacology

In sports, using illegal substances or techniques to improve performance is becoming very prevalent, which frequently kills the spirit of competition. The use of performance-enhancing drugs by athletes was reported to occur at rates varying from 5% to 31% by the regulatory organisations for sports. With the use of such drugs, athletes run the risk of suffering severe injuries and morbidities, which can result in poor health. Anabolic-androgenic steroids and their analogues, blood, erythropoietin, growth hormone and its derivatives, nutritional supplements, creatine, amphetamines, beta-hydroxy-beta-methyl butyrate (HMB), stimulants, and analgesics are some of the substances that are frequently misused in sports. Studying the different facets of drug use and abuse in sports, as well as providing medical care for sports-related injuries, are all included in sports pharmacology.

Track 11: Vaccines & its types

Vaccines train the body's immune system to recognise and fight against dangerous microbes. They come in the form of injections (shots), liquids, pills, or nasal sprays.

Types of Vaccines:

A reduced version of the germ is used in live-attenuated vaccines.
The germ is destroyed and used in inactivated vaccines.
The only components of the germ that are used in subunit, recombinant, polysaccharide, and conjugate vaccines are its protein, sugar, or packaging.
vaccines known as toxoids that use a toxin, a toxic byproduct of the germ.
mRNA vaccines use messenger RNA, which instructs your cells to produce a protein (or component of a protein) from the embryo.
The genetic material used in viral vector vaccines provides your cells with the directions they need to produce the germ's protein.

Track 12: Toxicology & its types

The scientific study of harmful impacts caused by chemicals on living things is known as toxicology. It entails keeping track of and documenting symptoms that appear after exposure to toxic chemicals. The dose of the substance is a crucial element in toxicology because it significantly affects the effects that the person will feel. In toxicology, the word "LD50" refers to the amount of a substance that will cause 50% of a test population to perish.

Specific areas of toxicity

There are various divisions of toxicology, each of which concentrates on different facets of the discipline. These consist of:

Toxicogenomic
Aquatic toxicology
Chemical toxicology
Clinical toxicology
Ecotoxicology
Environmental toxicology
Forensic toxicology
Medical toxicology
Occupational toxicology
Regulatory toxicology

Track 13: Regenerative Medicine & Tissue Engineering

Tissue Engineering is the process of combining scaffolds, cells, and biologically active molecules to create functional tissues. It developed from the area of biomaterials development. Creating functional constructs that repair, sustain, or enhance damaged tissues or entire organs is the aim of tissue engineering. Designed tissues include artificial epidermis and cartilage.

Research on self-healing, in which the body uses its own mechanisms, occasionally with assistance from external biological material, to recreate cells and rebuild tissues and organs, is also included in the wide field of regenerative medicine. As the field strives to concentrate on cures rather than treatments for complex, frequently chronic illnesses, the words "tissue engineering" and "regenerative medicine" have largely come to be used interchangeably.

Track 14: Drug Discovery & Development

Drug Discovery:

New understandings into the pathophysiology of an illness that enable researchers to create a product to halt or reverse the effects of the disease.
Molecular compounds have undergone numerous tests to determine any potential therapeutic benefits against a wide range of illnesses.
treatments currently in use that have unexpected consequences.
new technologies, like those that offer new methods to manipulate genetic material or target medical products to particular body parts.

Drug Development

When a potential compound is chosen for development, researchers run tests to learn more about: how it is metabolized, dispersed, and eliminated.

Its possible advantages and methods of operation.

The ideal dose.
The ideal dosage for the medication (such as by mouth or injection).
Toxicity is the term for bad reactions or side effects.
How it differs depending on the gender, race, or ethnicity of a group of individuals.
how it works with different medications and therapies.
its efficacy in comparison to equivalent medications.

Track 15: Drug Delivery Systems

Systems for delivering medications into or throughout the body are known as drug delivery systems. The delivery technique, such as a pill you swallow or an injection of a vaccine, is one of these technologies. Drug "packaging"—such as a micelle or a nanoparticle—that shields the drug from deterioration and enables it to move wherever it is needed in the body is referred to as drug delivery systems. The targeted distribution of medications will be made easier and their side effects will be lessened with further advancements in this field. Routes of delivery and delivery vehicles are the two general categories into which current research on drug delivery systems can be divided.

Delivery Routes

There are many different methods to take medications, including by injection, inhalation, skin absorption, and swallowing. Vaccination without discomfort using a microneedle patch: Because of their small size, the needles can transport medications painlessly even though they penetrate the epidermis and do not reach the nerves. Robotic pill for complicated drug oral administration.

Delivery Vehicles

By enabling the medication to go precisely where it needs to go, drug delivery vehicles can enhance drug targeting.

Sub tracks:

Challenges in Drug Delivery Systems
Advances in Drug Delivery Systems
Nanotechnology and Drug carrier systems
Novel Drug Delivery Systems
Alternative Drug Delivery Systems
Peptides and Protein Drug Delivery Systems

Track 16: Clinical Trials

The role that drugs trials play in the development of new medications, their stages, and the numerous ethical problems that could arise in clinical trials. It identifies key elements of drug trials that the healthcare team—including doctors, nurses, technicians, pharmacists, and data analysts—needs to comprehend in order to analyse and comprehend the findings of clinical trials and use this understanding to guide their patient care.

Objectives:

Describe the different stages of drug studies.
Describe the moral and social dilemmas that frequently arise during drug trials.
Describe the therapeutic importance of drug trials in brief.
Describe the significance of interprofessional team collaboration and coordination in enhancing research results, ensuring transparency, and ensuring proper application of data from drug trials.

Track 17: 2D and 3D printing

The academic community is using 2D and 3D printing more and more in the pharmaceutical industry (for medical devices and drugs), and more recently, they have begun to be used to make drugs in industry and hospitals. In 2018, a hospital pharmacy in Great Britain conducted the first clinical study using drugs that were 3D printed. One of the tools for a more personalised approach to medicine is 2D-3D printing, with additive printing techniques enabling the creation of polypills—tabs holding multiple medications—and the creation of specially formulated drugs with modified half-lives. This strategy might enable safer manufacturing and greater acceptance of the final product. Highlighting pertinent printing technologies for use in hospital pharmacies is the goal of this effort.

Track 18: Pharmaceutical Digital Marketing

Pharmaceutical digital marketing employs a number of digital strategies and platforms that are common in other industries, though frequently in ways that are unique to the life sciences. Pharma must make sure that all digital interactions and patient outreach adhere to all regulations because it is a regulated sector. Some digital platforms and strategies are unique to the pharmaceutical industry and were frequently created to support the top-notch scientific and medical conversations that businesses offer HCPs.

Track 19: Nutraceuticals

Nutraceuticals are products made from food sources that offer additional health advantages over and above the fundamental nutritional value found in food. The use of nutritional supplements to support overall health, manage symptoms, and stop cancerous processes can be viewed as a non-specific biological therapy. Dietary supplements, functional foods, therapeutic foods, and pharmaceuticals are the four main groups into which nutraceuticals are typically divided.

Track 20: Cosmeceuticals

"A topical preparation that is sold as a cosmetic but has performance characteristics that suggest pharmaceutical action" is referred to as cosmeceuticals. The field of cosmeceuticals has been growing almost rapidly, thanks to discoveries like alpha-hydroxy acids for exfoliation and skin rejuvenation, various topical vitamin C formulations, and an abundance of antioxidants, among others. The word "cosmeceutical," which described a new class of cosmetic products that offered effects beyond simple cosmetic enhancement but didn't meet the criteria for a drug or pharmaceutical, gained more traction as it became more appropriate.

Track 21: Medicinal Chemistry

Designing and synthesising biologically active compounds is the focus of pharmaceutical (medical) chemistry. The objective is to acquire new chemical molecules that could help in the finding of new pharmaceuticals or optimise already known drug structures, thereby increasing the variety of chemical drugs. Even though organic chemistry is essential, only skilled pharmaceutical chemists are able to collaborate with scientists from a variety of fields, including molecular biology, structural biology, pharmacology, physical chemistry, biochemistry, pharmacokinetics, pharmaceutical technology, toxicology, and translational medicine.

Market Analysis

GLOBAL PHARMA MARKET

Over 238 billion dollars were invested on research and development by the Pharmaceutical Conferences globally in 2021. R&D expenditures totalled 137 billion USD in 2012. Pre-clinical chemical testing and fundamental disease process study are both included in pharmaceutical R&D, which spans all stages of clinical trial development. A governmental body is involved at a specific step of the process, usually during the pre-clinical phase, to examine, supervise, and ultimately approve the drug. In the US, the primary agency in charge of procedures is the Food and Drug Administration.

Over the past few years, significant improvements in pharmaceutical research and development have begun to change the R&D ecosystem. A significant percentage of pharmaceutical companies' R&D is being contracted out to clinical research organizations, also known as contract research organizations, with the main objective of reducing costs. An additional important development is the use of big data in clinical research. In order to develop drugs that are both safer and more efficient, it is therefore possible to develop a prediction model that combines clinical and molecular data. Real-time or real-world evidence (RWE) in particular is getting more and more attention. Working with tech companies is required, and material from various sources, including social media, is incorporated. The Business study Company is a market and consumer study leader in the business world. It is located all over the globe and has experts in a range of fields, including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model, the company's flagship product, is a platform for market intelligence that provides a broad variety of macroeconomic measures and indicators for 60 various geographic locations and 27 various industries. For its consumers, the Global Market Model contains multi-layered statistics that help identify supply-demand gaps.

UAE PHARMA MARKET

Due to the growing healthcare sector and investments made in it, the UAE pharmaceutical market is expected to develop at an impressive CAGR during the forecast period of 2023–2027. The UAE pharmaceutical industry will expand over the next five years as a result of escalating demand from the nation's expanding population for effective pharmaceutical products. The government of the United Arab Emirates is constantly working to advance the pharmaceutical sector. Due to its potential for future development, export potential, and medium- to long-term economic effect, the pharmaceutical industry is a focus of initiatives like the Dubai Industrial Strategy 2030 and the Abu Dhabi Vision 2030.

The country's pharmaceutical needs were previously largely satisfied by foreign medications and pharmaceutical goods. Through increased investments in the research and development of pharmaceutical and therapeutic products, the nation is actively working to reduce the import of pharmaceuticals and make their own products going forward.

Competitive Environment

Company Profiles: Detailed analysis of the main pharmaceutical companies operating in the UAE.
Gulf Pharmaceutical Industries, Julphar
Consumer Health by Bayer
Health Pharma FZE
Pharmaceutical Company Niner
Neopharma and GlaxoSmithKline
UK Pfizer
Middle East Johnson & Johnson FZ-LLC
Report's Purpose

Pharmaceutical Industry in the UAE, By Drug Type:

Generic Medicine
Branded Medicines

Pharmaceutical Industry in the UAE, By Product Type:

Drugs on Prescription
Non-prescription Drugs

Pharmaceutics Market in the UAE, By Application:

Cardiovascular
Musculoskeletal
Oncology
Anti-infective
disorder of metabolism
Others

UAE Pharmaceutical Market by Channel of Distribution:

Market pharmacy
Healthcare Pharmacy
E-Pharmacy

Pharmaceutical Industry in the UAE, By Region:

Region of Dubai
Region of Sharjah
Region of Abu Dhabi
remaining UAE

DUBAI PHARMA MARKET

Dubai: The Next Pharma Hub

Dubai is keen on luring pharmaceutical firms. Dubai recently made the decision to cut its pharmaceutical shipments by 18% by the end of 2022 (from US$ 4 billion). Dubai is the best gateway to the Middle East to emerge as the pharmaceutical hub. By luring pharma companies to its soil, Dubai can become the MENA region's pharmaceutical hub and protect itself against pandemic-like situations that could lead to supply chain disruptions. Dubai Municipality is already working with Brinton Pharmaceuticals, which has a significant footprint in the dermatology, pediatric, respiratory, and family physician fields. A Covid-19 antiviral drug called Favipiravir was exported by the firm to Gulf nations the previous year. Dubai is seeking to work with businesses outside of the pharmaceutical industry in other healthcare sectors.

Past Conference Report

The 8th International Conference on Pharmaceutics & Advanced Drug Delivery Systems, which will take place in Dubai, UAE on December 04–06, 2023, is anticipated by the Pharmaceutical Science organizing team after the success of the 7th International Conference on Pharmaceutics & Advanced Drug Delivery Systems. The Pharmaceutical Sciences Conference featured a commixture of exceptional keynote and plenary speakers who imparted their knowledge on various cutting-edge subjects to the audience.

The Allied Academies organized this illustrious meeting, which drew participants from more than 30 nations, including renowned research scientists, business titans, and vibrant young research communities. The keynote forum was superbly introduced to begin the Pharmaceutical Sciences Conference. All of the speakers made valuable contributions to the success of the congress by giving insightful presentations.

For their efforts, the organising committee members, distinguished lecturers, budding scientists, delegates, and students are all thanked by the Allied Academies. We would like to express our gratitude to everyone who helped make this gathering a success.

Day - 1

Keynote Speakers:

Kwame Osei Owusu | Essex Partnership University NHS Foundation Trust | UK

John Coleman | Orderly Disruption Limited | UK

Charles Lowe | Digital Health & Care Alliance (DHACA) | UK

Morning Session

Chair: Kwame Osei Owusu | Essex Partnership University NHS Foundation Trust | UK

Sessions Covered: Novel Drug Delivery Systems | Drug Formulations | Pharmacology | Drug Development | Nanotechnology and Drug carrier Systems

Plenary Speakers:

Azadeh Motavallian | Erasmus University Medical Center | Netherlands

Marilena Vlachou | University of Athens | Greece

Clelia Dallanoce | University of Milan | Italy

Christer Halldin | Karolinska Institute Stockholm | Sweden

Oluwasegun Chijioke Adekoya | Tshwane University of Technology | South Africa

Afternoon Session

Chair: Charles Lowe | Digital Health & Care Alliance (DHACA) | UK

Plenary Speakers:

Angeliki Siamidi | National and Kapodistrian University of Athens | Greece

Ariya Chaisawadi | BPCL KMUTT | Thailand

Nafees Ahemad | Monash University | Malaysia

Joshua Newington | University of Cambridge | UK

Angeliki Siamidi | National and Kapodistrian University of Athens | Greece

Ivonka Valova | RIDACOM Greece Ltd | Bulgaria

Derek Beatty | Edinburgh University | UK

Shafiq Nakibinge | Uganda Institute of Allied Health and Management Sciences | Uganda

Poster Presentation

Nikolet Pavlova | Sofia University “St. Kliment Ohridski” | Bulgaria

The meeting of day 1 completed successfully with the thank you note, group photo, networking events and closing ceremony.

Day - 2

Keynote Speakers:

Manti S, Giallongo A | Leonardi University of Messina |Italy

Valeria Conti | University of Salerno | Italy

Morning Session

Chair: Manti S, Giallongo A | Leonardi University of Messina | Italy

Sessions Covered: Clinical Chemistry | Telepharmacy | Drug Development | Pharmacokinetics | Drug Delivery

Plenary Speakers:

Bayan Alkhawaja | University of Petra | Jordan

Hala J. Al-Obaidi | Ajman University | UAE

Joon Kim | Korea University | Republic of Korea

Mohamed El fadili | University Sidi Mohamed Ben Abdellah (USMBA) | Morocco

Muhammad Ashraf | Ain Shams University | Egypt

Afternoon Session

Chair: Valeria Conti | University of Salerno | Italy

Plenary Speakers:

Afsar Ahmed | King Abdulaziz University | Saudi Arabia

Tabinda Hassan | Princess Nourah University | Saudi Arabia

Itumeleng Daisy Makgato | Tshwane University of Technology | South Africa

Mohammad Ashfaq | Chandigarh University | India

Sravya Maddukuri | GITAM Deemed to be University | India

Anas M Hanif | Jinnah Sindh Medical University | Dow University of Health

Sciences | Pakistan

Mahvash Ansari Bahauddin | Zakariya University Multan | Pakistan

Mouqadas-Un-Nisa Bahauddin | Zakariya University Multan | Pakistan

Adel Abdollahnia | Shahid Beheshti University | Iran

Mohammad Mehdi Ghanbari | Islamic Azad University | Iran

E-Poster Presentation

Martin Rief | Medical University of Graz | Austria

Mirna PerkušiÄ? | University of Zagreb | Croatia

The meeting of day 2 completed successfully with the thank you note networking events and closing ceremony

Registration Details & Metrics

Participants may apply by paying the following fees:

Regulations for Registration

Participants who have registered are urged to quickly notify the respective program manager of their payments.
There will be a limit of one author or co-author per registration.
Ensure that you receive your formal invitation letter between 24 and 48 hours after registering.

Speaker Registration – 999$

Package A (Registration + 2 Night's Accommodation) – 1199$

Package B (Registration + 3 Night's Accommodation) – 1299$

Delegate Registration – 849$

Package A (Registration + 2 Night's Accommodation) – 1049$

Package B (Registration + 3 Night's Accommodation) – 1199$

Scholars Forum (Oral) – 449$

Student Poster – 399$

Student Delegate – 299$

Package A (Registration + 2 Night's Accommodation) – 699$

Package B (Registration + 3 Night's Accommodation) – 849$

VIRTUAL REGISTRATION

Virtual Speaker – 249$

Virtual Listener – 299$

E- Poster – 199$

Video Presentation – 249$

SPONSORSHIP & EXHIBITION

Elite Sponsor – 6500$

Gold Sponsor – 5000$

Silver Sponsor – 3500$

Exhibition – 2000$

Virtual Exhibition – 499

Organizing committee members

John Matsoukas

University of Calgary, Canada

Wieslaw Swietnicki

Hirszfeld Institute of Immunology and Experimental Therapy of the PAS, Poland

Baruch Barzel

Bar-Ilan University, Israel

Kwame Osei Owusu

Essex Partnership University NHS Foundation Trust, UK

Charles Lowe

Digital Health & Care Alliance (DHACA), UK

Dr. Gary Heng liang

Fu Jen Catholic University, Taiwan

Dr Alan Goldhamer

Founder

TrueNorth Health Center, USA

Dr Ignacio Quiles Lara

Board of Directors

WBY Ventures, USA

Dr Wieslaw Swietnicki

IITD PAN, Poland

Dr. Joseph P. Fuhr, Jr

Emeritus Professor, Pharmacoeconomics

University of Sciences, USA

Jorge González Borroto

Doctor, Pharmacovigilance

Ferrer Internacional, Spain

Dr Victor S. Dorodny

Founder and Chief Scientist

Naturopathy and traditional Medical Science, Naturopathic Evidence-based Wellness (NEW™) Institute, USA

Dr. Niranjan Koirala, PhD

Scientist, Biotechnology

University of Macau, Macau SAR, China

Renowned Speakers

Giuseppina Ioele

University of Calabria, Italy

Jae-Yong Lee

Hallym University, South Korea

Daniele Nosi

University of Florence, Italy

Eva Falomir

Universitat Jaume I, Spain

Beatriz Chamorro Gorines

University Camilo José Cela, Spain

Evgeniy Protasov

Russian Academy of Sciences, Russia

Ronak Tilvawala

University of Kansas, USA

Yishai Shimoni

IBM Research – Haifa, Israel

Xinyuan Chen

University of Rhode Island, USA

Atul Sharma

University of Medical Sciences, India

Mohamed Nabil

Deraya University, Egypt

Stefania Costa

University of Ferrara, Italy

Valeria Conti

University of Salerno, Italy

Daniela Imperio

University of Eastern Piedmont “A.Avogadro”, Italy

Andrea Calcaterra

Sapienza University of Rome, Italy

Israa Seliem

Zagazig University, Egypt, Egypt

Munirah A. Almessiere

Imam Abdulrahman Bin Faisal University, Saudi Arabia

Chrishan S. Samuel

Monash University, Australia, Australia

Flavia Zacconi

Pontificia Universidad Católica de Chile, Chile

Jelena Jovanovic

Institute of General and Physical Chemistry, Serbia

To Collaborate Scientific Professionals around the World

Conference Date	December 04-06, 2023
Poster Oppurtunity	Available
e-Poster Oppurtunity	Available

Testimonials

Andrea Calcaterra

Sapienza University of Rome, Italy

Dear Luna, I really appreciated participating in the Pharmaceutical Sciences 2021 International Podcast. Thank you for this opportunity. Best regards, Andrea

Atul Sharma

SGT University of Medical Sciences, India

Dear Luna, It was really a pleasure to be part of such a wonderful event. Regards Atul

Chrishan Samuel

Monash University, Australia

Thanks again Luna for reaching out to me to be involved in the Webinar. I enjoyed the presentations.

Fedora Grande

University of Calabria, Italy

Dear Luna, Thanks a lot for your email and your precious support during the conference preparation and in the final steps. It has been a wonderful experience.

Flavia Zacconi

Pontificia Universidad Católica de Chile, Chile

Dear Luna, The conference was excellent according to the one-day presentations, congratulations to all of you as organizers.

John Matsoukas

University of Victoria, Vancouver

Dear Luna, I enjoyed very much the meeting and I thank the organizing committee for the invitation! Best regards, John Matsoukas

Mohamed Nabil

Deraya University, Egypt

Greetings Luna Thanks a lot for giving me the opportunity to be one of the speakers in your respectable conference. I appreciate this, and honored to be involved in your upcoming organized events. Best regards.

MunIirah Abdullah Almessere

Imam Abdulrahman Bin Faisal University, Saudi Arabia

I would like to thank you to give this chance to be a speaker with these big names.

Sivakumar Sivagurunathan Moni

JAZAN UNIVERSITY, Saudi Arabia

It is my pleasure to share the view on 6th edition of the Pharmaceutical Sciences International, was very nice and high informative with various Scientist presentations. It was a wonderful experience; very valuable information's.

Sudershan Kumar

Unichlem Laboratories, India

Dear Dr. Luna, It was a highly memorable moment for me as well. I could listen to the highly impactful research excerpts from learned researchers in all various fields of research.

Tabinda Hasan

Princess Nourah bint Abdulrahman University, Saudi Arabia

The conference was exceptional and very informative. It was well organized and we learnt a lot from the sessions. Presenters and moderators did a great job.

Nikolet Pavlova

Sofia University “St. Kliment Ohridski”, Bulgaria